about
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder de...
Read More
2.62
-0.05
(-1.87%)
6,035
XNAS Volume
XNAS 29 Jan, 2026 4:30 PM (EST)
Board Meeting
The latest board meeting for Pulmatrix Inc took place on 29 Jan 2026, for the purpose of Pulmatrix Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Pulmatrix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..